Celebrating 25 years Est 1999-2024
*Across 3 years $2158.56 only $1079.28
Genmab Announces Financial Results for the First Half of 2024 August 8, 2024 Copenhagen, Denmark; Interim Report for the First Six Months Ended...
Genmab Updates 2024 Financial Guidance Company Announcement Genmab updates its 2024 financial guidanceIncrease in revenue driven by higher...
Genmab Takes Full Control of Acasunlimab Development Program Company Announcement Genmab to assume sole responsibility for the continued...
Genmab Announces Net Sales of DARZALEX® (daratumumab) for Second Quarter of 2024 Company Announcement Net sales of DARZALEX® in the second...
Epcoritamab (TEPKINLY®) Receives Positive CHMP Opinion for the Treatment of Adults with Relapsed/ Refractory Follicular Lymphoma Company...
Completion of Share Buy-back Program Company Announcement COPENHAGEN, Denmark; June 27, 2024 – Genmab A/S (Nasdaq: GMAB) announces that...
EPKINLY® (epcoritamab-bysp) Approved by U.S. FDA for Patients with Relapsed or Refractory (R/R) Follicular Lymphoma (FL) Company Announcement...
Transactions in Connection with Share Buy-back Program Company Announcement COPENHAGEN, Denmark; June 24, 2024 – Genmab A/S (Nasdaq: GMAB...
Capital Increase in Genmab as a Result of Employee Warrant Exercise Company Announcement COPENHAGEN, Denmark; June 18, 2024 – Genmab A/S...
Transactions in Connection with Share Buy-back Program Company Announcement COPENHAGEN, Denmark; June 17, 2024 – Genmab A/S (Nasdaq: GMAB...
Grant of Restricted Stock Units and Warrants to Employees in Genmab Company Announcement COPENHAGEN, Denmark; June 12, 2024 – Genmab A/S...
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons Company...
Transactions in Connection with Share Buy-back Program Company Announcement COPENHAGEN, Denmark; June 10, 2024 – Genmab A/S (Nasdaq: GMAB...
Genmab to Participate in a Fireside Chat at the Goldman Sachs 45th Annual Global Healthcare Conference Media Release COPENHAGEN, Denmark;...
Transactions in Connection with Share Buy-back Program Company Announcement COPENHAGEN, Denmark; June 3, 2024 – Genmab A/S (Nasdaq: GMAB). On...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.